AvoCog - the Effect of Daily Avocado Intake on Cognitive Function in Older Adults

ConditionBrain Aging
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-85
SponsorUniversity of Kansas Medical Center

About this trial

The goal of this clinical trial is to determine if adding avocados to the diet of impacts cognition in 70 older adults, age 65-85, without dementia. We will test for change in functional MRI, cognitive performance, and brain blood flow. Intervention group participants will be asked to consume 1 avocado per day for 12 weeks. Participants in the control group will be asked to continue their normal intake for 12 weeks. Throughout the study, participants will be asked to perform cognitive tests, MRI, blood tests, and questionnaires.

Eligibility criteria

Qualifiers

Males and females aged 65-85 years

Good general health with no concomitant disease

BMI 18.5 - 35 kg/m2

Mini Mental State Exam ≥26

Disqualifiers

Unwilling or unable to consume avocado

Latex allergy

Consistently taking lutein + zeaxanthin supplements

Skin carotenoid content ≥400

Trial design

Treatments tested in this trial

  • Avocado Group

Treatment groups

70 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Kansas Medical Center

Lead sponsor

Avocado Nutrition Center

Collaborator